http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 22 Jun 2026 16:16:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+Jun+17/26673306.html si-local-file:///var/storage/secattach/20260622/26673306.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+Jun+17/26673306.html Mon, 22 Jun 2026 16:16:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+Jun+17/26673306.html si-local-file:///var/storage/secattach/20260622/26673306.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+Jun+17/26673306.html Mon, 22 Jun 2026 16:16:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Genvor+Inc++++++++++++++++For%3A+May+18++Filed+by%3A+Kalkofen+Donald+A./26550324.html si-local-file:///var/storage/secattach/20260526/26550324.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Genvor+Inc++++++++++++++++For%3A+May+18++Filed+by%3A+Kalkofen+Donald+A./26550324.html Tue, 26 May 2026 16:20:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Genvor+Inc++++++++++++++++For%3A+May+18++Filed+by%3A+Kalkofen+Donald+A./26550324.html si-local-file:///var/storage/secattach/20260526/26550324.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Genvor+Inc++++++++++++++++For%3A+May+18++Filed+by%3A+Kalkofen+Donald+A./26550324.html Tue, 26 May 2026 16:20:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+May+18/26535524.html si-local-file:///var/storage/secattach/20260521/26535524.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+May+18/26535524.html Thu, 21 May 2026 16:16:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+May+18/26535524.html si-local-file:///var/storage/secattach/20260521/26535524.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+May+18/26535524.html Thu, 21 May 2026 16:16:00 -0400 GNVR O.59064674 http://www.streetinsider.com/Management+Changes/Genvor+names+Donald+Kalkofen+as+chief+financial+officer/26531656.html <p>Genvor Inc. (OTCQB: GNVR) appointed Donald Kalkofen as chief financial officer, according to a company statement. Kalkofen will oversee the biotechnology company's financial strategy as it pursues commercialization plans in agriculture and human health markets.</p> <p>Kalkofen brings more than 20 years of CFO experience across biotechnology, financial services, and technology sectors. He most recently served as CFO of Alpha Cognition Inc., a publicly traded biotechnology company focused on neurodegenerative disease treatments, where he led preparations for the company's NASDAQ listing. Prior to that role, he was CFO at Protagonist Therapeutics, a clinical-stage biopharmaceutical company.</p> <p>Earlier in his career, Kalkofen held CFO positions http://www.streetinsider.com/Management+Changes/Genvor+names+Donald+Kalkofen+as+chief+financial+officer/26531656.html Thu, 21 May 2026 08:00:24 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Management+Changes/Genvor+names+Donald+Kalkofen+as+chief+financial+officer/26531656.html <p>Genvor Inc. (OTCQB: GNVR) appointed Donald Kalkofen as chief financial officer, according to a company statement. Kalkofen will oversee the biotechnology company's financial strategy as it pursues commercialization plans in agriculture and human health markets.</p> <p>Kalkofen brings more than 20 years of CFO experience across biotechnology, financial services, and technology sectors. He most recently served as CFO of Alpha Cognition Inc., a publicly traded biotechnology company focused on neurodegenerative disease treatments, where he led preparations for the company's NASDAQ listing. Prior to that role, he was CFO at Protagonist Therapeutics, a clinical-stage biopharmaceutical company.</p> <p>Earlier in his career, Kalkofen held CFO positions http://www.streetinsider.com/Management+Changes/Genvor+names+Donald+Kalkofen+as+chief+financial+officer/26531656.html Thu, 21 May 2026 08:00:24 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Management+Changes/Genvor+names+Donald+Kalkofen+as+chief+financial+officer/26531656.html <p>Genvor Inc. (OTCQB: GNVR) appointed Donald Kalkofen as chief financial officer, according to a company statement. Kalkofen will oversee the biotechnology company's financial strategy as it pursues commercialization plans in agriculture and human health markets.</p> <p>Kalkofen brings more than 20 years of CFO experience across biotechnology, financial services, and technology sectors. He most recently served as CFO of Alpha Cognition Inc., a publicly traded biotechnology company focused on neurodegenerative disease treatments, where he led preparations for the company's NASDAQ listing. Prior to that role, he was CFO at Protagonist Therapeutics, a clinical-stage biopharmaceutical company.</p> <p>Earlier in his career, Kalkofen held CFO positions http://www.streetinsider.com/Management+Changes/Genvor+names+Donald+Kalkofen+as+chief+financial+officer/26531656.html Thu, 21 May 2026 08:00:24 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Management+Changes/Genvor+names+Donald+Kalkofen+as+chief+financial+officer/26531656.html <p>Genvor Inc. (OTCQB: GNVR) appointed Donald Kalkofen as chief financial officer, according to a company statement. Kalkofen will oversee the biotechnology company's financial strategy as it pursues commercialization plans in agriculture and human health markets.</p> <p>Kalkofen brings more than 20 years of CFO experience across biotechnology, financial services, and technology sectors. He most recently served as CFO of Alpha Cognition Inc., a publicly traded biotechnology company focused on neurodegenerative disease treatments, where he led preparations for the company's NASDAQ listing. Prior to that role, he was CFO at Protagonist Therapeutics, a clinical-stage biopharmaceutical company.</p> <p>Earlier in his career, Kalkofen held CFO positions http://www.streetinsider.com/Management+Changes/Genvor+names+Donald+Kalkofen+as+chief+financial+officer/26531656.html Thu, 21 May 2026 08:00:24 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Press+Releases/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html <p>Woodland, CA, May 21, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“Genvor”), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced the appointment of Donald Kalkofen as Chief Financial Officer. In this role, Mr. Kalkofen will lead Genvor’s financial strategy as the company advances its dual-market commercialization plans across agriculture and human health and wellness.</p> <p>Mr. Kalkofen brings more than 20 years of Chief Financial Officer experience leading finance and operations across biotechnology, financial services, and technology, with a proven track record of guiding companies http://www.streetinsider.com/Press+Releases/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html Thu, 21 May 2026 08:00:00 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Press+Releases/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html <p>Woodland, CA, May 21, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“Genvor”), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced the appointment of Donald Kalkofen as Chief Financial Officer. In this role, Mr. Kalkofen will lead Genvor’s financial strategy as the company advances its dual-market commercialization plans across agriculture and human health and wellness.</p> <p>Mr. Kalkofen brings more than 20 years of Chief Financial Officer experience leading finance and operations across biotechnology, financial services, and technology, with a proven track record of guiding companies http://www.streetinsider.com/Press+Releases/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html Thu, 21 May 2026 08:00:00 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Press+Releases/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html <p>Woodland, CA, May 21, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“Genvor”), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced the appointment of Donald Kalkofen as Chief Financial Officer. In this role, Mr. Kalkofen will lead Genvor’s financial strategy as the company advances its dual-market commercialization plans across agriculture and human health and wellness.</p> <p>Mr. Kalkofen brings more than 20 years of Chief Financial Officer experience leading finance and operations across biotechnology, financial services, and technology, with a proven track record of guiding companies http://www.streetinsider.com/Press+Releases/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html Thu, 21 May 2026 08:00:00 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Press+Releases/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html <p>Woodland, CA, May 21, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“Genvor”), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced the appointment of Donald Kalkofen as Chief Financial Officer. In this role, Mr. Kalkofen will lead Genvor’s financial strategy as the company advances its dual-market commercialization plans across agriculture and human health and wellness.</p> <p>Mr. Kalkofen brings more than 20 years of Chief Financial Officer experience leading finance and operations across biotechnology, financial services, and technology, with a proven track record of guiding companies http://www.streetinsider.com/Press+Releases/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html Thu, 21 May 2026 08:00:00 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Globe+Newswire/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html <p>Woodland, CA, May 21, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“Genvor”), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced the appointment of Donald Kalkofen as Chief Financial Officer. In this role, Mr. Kalkofen will lead Genvor’s financial strategy as the company advances its dual-market commercialization plans across agriculture and human health and wellness.</p> <p>Mr. Kalkofen brings more than 20 years of Chief Financial Officer experience leading finance and operations across biotechnology, financial services, and technology, with a proven track record of guiding companies http://www.streetinsider.com/Globe+Newswire/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html Thu, 21 May 2026 08:00:00 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Globe+Newswire/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html <p>Woodland, CA, May 21, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“Genvor”), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced the appointment of Donald Kalkofen as Chief Financial Officer. In this role, Mr. Kalkofen will lead Genvor’s financial strategy as the company advances its dual-market commercialization plans across agriculture and human health and wellness.</p> <p>Mr. Kalkofen brings more than 20 years of Chief Financial Officer experience leading finance and operations across biotechnology, financial services, and technology, with a proven track record of guiding companies http://www.streetinsider.com/Globe+Newswire/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html Thu, 21 May 2026 08:00:00 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Globe+Newswire/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html <p>Woodland, CA, May 21, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“Genvor”), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced the appointment of Donald Kalkofen as Chief Financial Officer. In this role, Mr. Kalkofen will lead Genvor’s financial strategy as the company advances its dual-market commercialization plans across agriculture and human health and wellness.</p> <p>Mr. Kalkofen brings more than 20 years of Chief Financial Officer experience leading finance and operations across biotechnology, financial services, and technology, with a proven track record of guiding companies http://www.streetinsider.com/Globe+Newswire/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html Thu, 21 May 2026 08:00:00 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/Globe+Newswire/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html <p>Woodland, CA, May 21, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“Genvor”), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced the appointment of Donald Kalkofen as Chief Financial Officer. In this role, Mr. Kalkofen will lead Genvor’s financial strategy as the company advances its dual-market commercialization plans across agriculture and human health and wellness.</p> <p>Mr. Kalkofen brings more than 20 years of Chief Financial Officer experience leading finance and operations across biotechnology, financial services, and technology, with a proven track record of guiding companies http://www.streetinsider.com/Globe+Newswire/Genvor+Appoints+Donald+Kalkofen+as+Chief+Financial+Officer/26531633.html Thu, 21 May 2026 08:00:00 -0400 A.19550920 GNVR O.47833102 O.59064674 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Genvor+Inc++++++++++++++++For%3A+Mar+31/26486589.html si-local-file:///var/storage/secattach/20260513/26486589.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Genvor+Inc++++++++++++++++For%3A+Mar+31/26486589.html Wed, 13 May 2026 16:26:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Genvor+Inc++++++++++++++++For%3A+Mar+31/26486589.html si-local-file:///var/storage/secattach/20260513/26486589.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Genvor+Inc++++++++++++++++For%3A+Mar+31/26486589.html Wed, 13 May 2026 16:26:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+May+05/26470751.html si-local-file:///var/storage/secattach/20260511/26470751.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+May+05/26470751.html Mon, 11 May 2026 17:29:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+May+05/26470751.html si-local-file:///var/storage/secattach/20260511/26470751.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+May+05/26470751.html Mon, 11 May 2026 17:29:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+Apr+16/26349667.html si-local-file:///var/storage/secattach/20260422/26349667.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+Apr+16/26349667.html Wed, 22 Apr 2026 11:48:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+Apr+16/26349667.html si-local-file:///var/storage/secattach/20260422/26349667.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Genvor+Inc++++++++++++++++For%3A+Apr+16/26349667.html Wed, 22 Apr 2026 11:48:00 -0400 GNVR O.59064674 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Genvor+Inc++++++++++++++++For%3A+Apr+15++Filed+by%3A+Pawlak+Chad+Lee+Sr./26322942.html si-local-file:///var/storage/secattach/20260416/26322942.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Genvor+Inc++++++++++++++++For%3A+Apr+15++Filed+by%3A+Pawlak+Chad+Lee+Sr./26322942.html Thu, 16 Apr 2026 10:58:00 -0400 GNVR O.59064674